Cardiology Flashcards
Cocaine associated chest pain
percentage with AMI
6%
Acute myocardial infarction
anatomic difference STEMI vs NSTEMI
prognosis STEMI vs NSTEMI
STEMI: trans mural infarction, full thickness of myocardium
NSTEMI: seven the cardio, partial wall thickness
prognosis similar
Acute myocardial infarction
percentage with normal EKG
significant Q wave
percentage with normal EKG: 4%
significant Q wave: 1 square wide, 1/3 of height of R wave
Differential diagnosis of ST segment elevation
–Acute MI
–Prinzmetal’s angina (vasospasm)
–Pericarditis
–Ventricular wall aneurysm
–Benign early repolarization
–Bundle branch block
Prinzmetal’s angina - EKG diagnostic pearl to distinguish from STEMI (1)
LV aneurysm: EKG diagnostic pearl to distinguish from STEMI (4)
Prinzmetal: Usually no reciprocal depression
LV aneurysm:
No reciprocal depression
Qwaves present
Look for old ECGs — no change
No serial changes
Posterior MI EKG description
Posterior MI (ST-depression with tall R-waves and upright Ts in V1-2)
Sgarbossa criteria - use and description (2)
- ST-segment elevation measuring ≥1 mm concordant with the QRS in any lead.
- ST-segment depression measuring ≥1 mm in any of the V1 through V3 leads (concordant with the QRS).
Possible isolated posterior MI
ST-depression + tall R-waves in V1-2 + upright Ts
Diagnosis
MI in setting of LBBB - Sgarbossa: concordance in aVL, V5-6
Scarbosa:
- ST-segment elevation measuring ≥1 mm concordant with the QRS in any lead.
- ST-segment depression measuring ≥1 mm in any of the V1 through V3 leads (concordant with the QRS).
concordance in V3
MI by Scarbosa
- ST-segment elevation measuring ≥1 mm concordant with the QRS in any lead.
- ST-segment depression measuring ≥1 mm in any of the V1 through V3 leads (concordant with the QRS).
STE in aVR à acute LMCA occlusion
deWinter T-waves acute LAD occlusion
Normalization of ischemia-related ST elevation
Early T wave inversions can be highly specific markers of reperfusion
accelerated idioventricular rhythm (rate 60-120) AIVR
Predictors of reperfusion in AMI
accelerated idioventricular rhythm (rate 60-120) AIVR
Benign after reperfusion, don’t supress
Troponin rise, peak and normalization
•Troponin
–3-6 hours (rises)
–12-24 hours (peaks)
–7-10 days (normalizes)
AMI oral meds
•Beta blocker (metoprolol) early IV discouraged
–Give within 24 hours orally but no rush
–Contraindications (asthma, CHF, bradycardia, hypotension; caution in RV MI)
•Addl. platelet inhibitors (in ED or cath lab)
–GP Ilb/IIIa receptor antags IV
–Clopidogrel, ticagrelor: can give oral load
–Prasugrel 60 mg oral load at cath; avoid if history of TIA or stroke
AMI thrombolytic therapy indications (3)
symptoms greater than 30 minutes, less than 12 hours
STEMI EKG criteria (STE 2 contig, posterior STEMI, LBBB + Scarbossa)
PCI would be > 90 minutes
absolute contraindications to thrombolytic therapy (6)
- PCI immediately available
- Active bleeding from any site
- CVA within 6 months or hemorrhagic CVA at any time in the past
- Intracranial or intraspinal surgery or trauma within 2 months
- Intracranial or intraspinal neoplasm, aneurysm or AV malformation
- Suspected aortic dissection
Early AMI arrhythmias with poor prognosis (5)
–2˚ Mobitz II (progress to 3˚)
–3˚ AV block from anterior MI
–Persistent sinus tach, SVT, A-fib
–New BBB, bifascicular block (RBBB (RBBB + hemiblock)
–Left posterior hemiblock (large infarct size)
•Increased risk of pump failure, mortality
AMI valve dysfunction
•Acute mitral regurgitation (usually due to ischemic dysfunction of papillary muscles)
chest pain, hypertension, JVD, lungs CTA
inferior STEMI with RV infarct
late complications of MI - weeks
systemic (1)
Pericardial and eponym
Myocardial (3) and tx
systemic (1): embolism of mural thrombus
Pericardial and eponym: pericarditis, Dressler’s syndrome if approximately 2 to 8 week timeframe
Myocardial (3) and tx: acute mitral regurgitation from papillary muscle rupture, LV free wall rupture, septal wall rupture (acute VSD with CHF)
Tx -> Hemodynamic support, IABP, OR
high-output heart failure causes (5)
–Thyrotoxicosis
–Anemia
–A-V fistula
–Paget’s disease of the bone
–Beriberi
ssystolic dysfunction leads to high levels of (2) which in turn leads to (1)
renin and anngiotensin, high afterload
heart failure
afterload reduction: 3
preload reduction: 3
hypotension management: 2
afterload reduction: nitroglycerin, ACE inhibitor, nitroprusside
preload reduction: nitrates, diuretics, and nesiritdie
hypotension management: dobutamine, IABP
Endocarditis risk factors, less known (two)
valves affected, relative hierarchy
most common infective agent for IVDA and prosthetic valves
Endocarditis risk factors, less known (two): mitral valve prolapse, pacemaker
valves affected, relative hierarchy: –Mitral > aortic > tricuspid (IVDA) > pulmonic
most common infective agent for IVDA and prosthetic valves: staph aureus
Endocarditis
most common pathogen for acute and subacute forms
left-sided (2)
right-sided (3)
Common pathogen: staph aureus and strep viridans respectively
left-sided (2): –S. viridans, S. aureus
right-sided (3): –S. aureus, S. pneumoniae, gram negatives
Endocarditis, most common pathogens
prosthetic valve, early:
aesthetic valve, late:
prosthetic valve, early: •S. epidermidis, S. aureus
aesthetic valve, late: •S. viridans, Serratia, Pseudomonas
Endocarditis, cutaneous stigmata (4)
–Osler nodes: tender nodules on the tips of the fingers and toes (Osler = Ow!)
–Janeway lesions: nontender, hemorrhagic plaques on the palms and soles
–Roth spots: retinal hemorrhages with central clearing
–Petechiae and splinter hemorrhages
Endocarditis treatment antibiotics
x or y + z; add this for prosthetic valves
•penicillins or vancomycin, and add aminoglycoside
–Add rifampin for prosthetic valves
Endocarditis,
indications for prophylaxis
High-risk cardiac conditions + dental procedure
–Prosthetic cardiac valve
–History of infective endocarditis
–Congenital heart disease (CHD)
–Cardiac transplantation recipients with cardiac valvular disease
Endocarditis,
prophylaxis medication, PCN all alternative PO and IV
Aortic stenosis
contraindicated medications
Nitrates and vasodilators
Aortic regurgitation
acute and chronic etiologies (2 each)
–Acute: endocarditis, dissection
–Chronic: RHD; also seen with Marfan’s syndrome
Mitral valve stenosis
Associated arrhythmias
•atrial tachyarrhythmias
Etiology of chronic mitral regurgitation (4)
•Etiology of chronic MR
–MVP
–Dilated cardiomyopathy
–RHD
–Mitral annulus calcification
Medical management of mitral regurgitation
acute (2)
chronic (3)
•Medical management of acute MR
–Afterload reduction
–IABP to temporize until surgery
•Medical management of chronic MR
–Symptomatic treatment of CHF
–Treatment of A-fib
–Endocarditis prophylaxis (s/p replacement)
Mitral valve prolapse
Symptoms (4)
Complications (2)
Endocarditis proph?
•Symptoms
–Chest pain (atypical)
–Dyspnea
–Anxiety
–Palpitations (increased incidence of SVT)
complications: rare, arrhythmias, thromboembolic disease, rare endocarditis
prophylaxis: no; anticoagulation and beta blockers as needed